BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bolger JC, Donohoe CL, Lowery M, Reynolds JV. Advances in the curative management of oesophageal cancer. Br J Cancer 2022;126:706-17. [PMID: 34675397 DOI: 10.1038/s41416-021-01485-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Tavakoli I, Turner SR, Diaz-Gutierrez I. Presurgical radiation and chemotherapy in preparation for thoracic tumor resection. Curr Opin Anaesthesiol 2023;36:74-82. [PMID: 36550608 DOI: 10.1097/ACO.0000000000001224] [Reference Citation Analysis]
2 Liu J, Ma X, Cao L, Wei Y, Gao Y, Qu C, Maimaitiming N, Zhang L. Computational Drug Repurposing Approach to Identify Novel Inhibitors of ILK Protein for Treatment of Esophageal Squamous Cell Carcinoma. J Oncol 2022;2022:3658334. [PMID: 36618074 DOI: 10.1155/2022/3658334] [Reference Citation Analysis]
3 Mei PY, Xiao H, Guo Q, Meng WY, Wang ML, Huang QF, Liao YD. Identification and validation of DPY30 as a prognostic biomarker and tumor immune microenvironment infiltration characterization in esophageal cancer. Oncol Lett 2023;25:68. [PMID: 36644145 DOI: 10.3892/ol.2022.13654] [Reference Citation Analysis]
4 Jones CM, O'connor H, O'donovan M, Hayward D, Blasko A, Harman R, Malhotra S, Debiram-beecham I, Alias B, Bailey A, Bateman A, Crosby TD, Falk S, Gollins S, Hawkins MA, Kadri S, Levy S, Radhakrishna G, Roy R, Sripadam R, Fitzgerald RC, Mukherjee S. Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study. eClinicalMedicine 2022;53:101664. [DOI: 10.1016/j.eclinm.2022.101664] [Reference Citation Analysis]
5 Wang YM, Zhao QW, Sun ZY, Lin HP, Xu X, Cao M, Fu YJ, Zhao XJ, Ma XM, Ye Q. Circular RNA hsa_circ_0003823 promotes the Tumor Progression, Metastasis and Apatinib Resistance of Esophageal Squamous Cell Carcinoma by miR-607/CRISP3 Axis. Int J Biol Sci 2022;18:5787-808. [PMID: 36263172 DOI: 10.7150/ijbs.76096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yao X, Lu S, Feng C, Suo R, Li H, Zhang Y, Chen Q, Lu J, Wu B, Guo J. Tumor oxygenation nanoliposome synergistic hypoxia-inducible-factor-1 inhibitor enhanced Iodine-125 seed brachytherapy for esophageal cancer. Biomaterials 2022;289:121801. [PMID: 36137416 DOI: 10.1016/j.biomaterials.2022.121801] [Reference Citation Analysis]
7 J. Fitzgerald T, Laurie F, Iandoli M, Bishop-jodoin M, Smith K, Ulin K, Moni J, Giulia Cicchetti M, Kry S, Knopp M, Xiao Y, Rosen M, Prior F, Saltz J. Modern Clinical Trials in Radiation Oncology. Clinical Trials - Recent Advances [Working Title] 2022. [DOI: 10.5772/intechopen.107086] [Reference Citation Analysis]
8 Hung P, Chen H, Tu Y, Kao Y. A Comparison of Different Types of Esophageal Reconstructions: A Systematic Review and Network Meta-Analysis. JCM 2022;11:5025. [DOI: 10.3390/jcm11175025] [Reference Citation Analysis]
9 Chen F, Zhang J, Bai W, Formanowicz D. Establishment and Analysis of a Prognostic Model of Autophagy-Related lncRNAs in ESCA. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/9265088] [Reference Citation Analysis]
10 Vashist Y, Aigner K, Dam M, Gailhofer S, Aigner KR. Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative Treatment. Current Oncology 2022;29:4868-4878. [DOI: 10.3390/curroncol29070386] [Reference Citation Analysis]
11 Ferndale L, Aldous C. Oesophageal cancer in South Africa: A scoping review. South African Journal of Oncology 2022;6. [DOI: 10.4102/sajo.v6i1.217] [Reference Citation Analysis]
12 Stüben BO, Stuhlfelder J, Kemper M, Tachezy M, Ghadban T, Izbicki JR, Bokemeyer C, Sinn M, Karstens KF, Reeh M. Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal Adenocarcinoma. Cancers (Basel) 2022;14:1084. [PMID: 35205833 DOI: 10.3390/cancers14041084] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]